BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Amicus Therapeutics Announces Second Quarter 2023 Financial Results and Corporate Updates

  Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, today announced financial results for the second quarter ended June 30, 2023.

  August 8, 2023

   · 

  24 min read
• Pharm Country

  Bristol Myers Squibb Launches Clear Understanding Campaign to Reveal the Plain Truth About Living with Moderate to Severe Plaque Psoriasis

  Bristol Myers Squibb Launches Clear Understanding Campaign to Reveal the Plain Truth About Living with Moderate to Severe Plaque Psoriasis.

  August 8, 2023

   · 

  14 min read
• Business

  Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue Guidance

  Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS ® U.S. Net Sales and Ironwood Revenue Guidance.

  August 8, 2023

   · 

  34 min read
• Business

  Seres Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates

  Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today reported second quarter 2023 financial results and provided business updates.

  August 8, 2023

   · 

  19 min read
• Business

  Sofwave Medical Reports Second Quarter and First Half 2023 Financial Results and Recent Business Highlights

  Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, reported second quarter and first half fiscal 2023 financial results for the period ended June 30, 2023, and recent business highlights.

  August 8, 2023

   · 

  3 min read
• Business

  DiaMedica Therapeutics to Report Second Quarter 2023 Financial Results and Provide a Business Update August 15, 2023

  DiaMedica Therapeutics Inc. announced today that its second quarter 2023 financial results will be released after the markets close on Monday, August 14th.

  August 8, 2023

   · 

  1 min read
• Biotech Beach

  Spark™ Clear Aligners Announces Key Clinical Updates & Doctor-Driven Innovations in Release 14

  Ormco Corporation announces the highly anticipated Spark Clear Aligners Release 14. Release 14 continues Spark’s philosophy of giving orthodontists control and flexibility.

  August 8, 2023

   · 

  5 min read
• Pharm Country

  Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel

  Specialty cancer diagnostics company Precipio, Inc., announces the launch of its new quantitative BCR-ABL 2.0 panel, with features making it the most innovative panel of its kind on the market.

  August 8, 2023

   · 

  5 min read
• Drug Development

  Published Analysis of Sotagliflozin (INPEFA(TM)) Clinical Data Demonstrates Significant Reductions in the Risk of Hospital Readmissions for Heart Failure

  Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that a post hoc analysis of data from the SOLOIST-WHF Phase 3 outcomes study of sotagliflozin has been published by the Journal of the American College of Cardiology (JACC): Heart Failure.

  August 8, 2023

   · 

  11 min read
• Biotech Beach

  Endonovo’s Breaking Barriers in With Patented Medical Technologies: 2023 Bi-Annual Update

  Endonovo Therapeutics Inc. is proud to announce a series of advancements in the first half of 2023.

  August 8, 2023

   · 

  7 min read